Evraz Plans Key Investment Projects For 2021-26 To Secure EBITDA Growth Of Around $630 Mln

Steel company EVRAZ plc (EVR.L) Wednesday that for 2021-26 period, it is considering several key investment projects with the target to secure EBITDA growth in the amount of around $630 million.

The company is expecting the effect on EBITDA from the Steel segment's sales strategy execution to amount to around $300 million in 2026.

Average annual capital expenditures are expected to be around $1.0 billion per annum in 2021-2026. This includes plans to invest around $200 million in the environmental projects in 2022-2025.

EVRAZ will host its Capital Markets Day today, which will feature the presentation by EVRAZ executives.

The presentation will provide the status of the Potential Demerger of coal assets, an update on ESG targets and initiatives and steel business' growth strategy overview.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Cargill, Inc., a privately held food company, is recalling certain chocolate products containing recalled Jif peanut butter due to the potential for salmonella contamination, the U.S. Food and Drug Administration said. The recall involves 795, 8-ounce boxes of Wilbur brand products, such as Milk and Dark Chocolate Covered Peanut Butter Ritz Crackers, Peanut Butter Meltaways... The U.S. Food and Drug Administration approved Regeneron Pharmaceuticals, Inc.'s Dupixent (dupilumab) to treat eosinophilic esophagitis or EoE, a chronic immune disorder. It is the first FDA approval to treat EoE in adults and pediatric patients 12 years and older weighing at least 40 kilograms. Food products maker J. M. Smucker Co. has recalled select Jif peanut butter products sold in the United States due to potential Salmonella contamination, the U.S. Food and Drug Administration said. The recall involves various creamy, crunchy, natural, no added sugar, and reduced fat peanut butter, among others with lot codes 1274425 - 2140425.
Follow RTT